Pyrimidines as PLK inhibitors

US7241769B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Heinz Stadtmueller · Wien, AT
• Harald Engelhardt · Ebreichsdorf, AT
• Ulrich Reiser · Wien, AT
• Stephan Karl Zahn · Wien, AT
• Rudolf Hauptmann · Ebreichsdorf, AT
• Martin Steegmaier · Wien, AT
• Ulrich Guertler · Wien, AT
• Matthias Hoffmann · Mittelbiberach, DE
• Matthias Grauert · Ingelheim am Rhein, DE

Key dates

• Filing date: May 18, 2005
• Grant date: Jul 10, 2007
• Expiry date: May 18, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D403/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention comprises compounds of general formula (1)wherein